Trans-nasal Endoscopy for Bariatric Patients
Recruiting · NCT06200961 · Interventional (participants receive a specific treatment) · Lead sponsor: Christopher C. Thompson, MD, MSc
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Who can take part
Inclusion criteria
- Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
- Cared for in metabolic and bariatric clinic
Exclusion criteria
- Patient \<18 years of age
- Medically contraindicated to perform EGD or TNE
- Inability to provide informed consent
Where it is running
1 location listed across 1 US state.
- Brigham and Women's Hospital - Boston, Massachusetts, United States